Cancer of Unknown Primary With Presumptive Pancreatic Cancer Treated With FOLFIRINOX.
Cancer of unknown primary
FOLFIRINOX
Pathological autopsy
Journal
Journal of medical cases
ISSN: 1923-4163
Titre abrégé: J Med Cases
Pays: Canada
ID NLM: 101551824
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
14
10
2021
accepted:
28
10
2021
entrez:
22
11
2021
pubmed:
23
11
2021
medline:
23
11
2021
Statut:
ppublish
Résumé
A 52-year-old man was found to have an increase in carbohydrate antigen (CA)19-9. He underwent endoscopic ultrasound/fine needle aspiration (EUS-FNA) of the soft tissue shadow near the pancreas and was diagnosed with adenocarcinoma. The cancer was judged to be of unknown primary. Cancers of unknown primary make up 3-5% of malignant tumors, and it is difficult to determine the treatment policy. FOLFIRINOX's efficacy in cancer of unknown primary is unclear. In this case, he received chemotherapy with FOLFIRINOX. After five cycles of treatment, the best effect was stable disease (SD). However, he died about 6 months after the onset of symptoms. Pathological anatomy after death revealed that the primary lesion was in the pancreas. FOLFIRINOX may be effective for cancers of unknown primary. Pathological anatomy is important to confirm the validity of treatment. It is important to consider giving chemotherapy if there is a presumed primary tumor even if the cancer is of unknown primary.
Identifiants
pubmed: 34804303
doi: 10.14740/jmc3812
pmc: PMC8577614
doi:
Types de publication
Case Reports
Langues
eng
Pagination
442-445Informations de copyright
Copyright 2021, Inoue et al.
Déclaration de conflit d'intérêts
None to declare.
Références
J Investig Med High Impact Case Rep. 2013 Jun 18;1(2):2324709613494830
pubmed: 26425578
Eur J Cancer. 2012 Mar;48(5):721-7
pubmed: 22317952
Br J Cancer. 2013 Jan 15;108(1):39-48
pubmed: 23175147
Clin Transl Oncol. 2018 Jan;20(1):89-96
pubmed: 29230692
Cancer J. 2010 Jan-Feb;16(1):70-5
pubmed: 20164695
Crit Rev Oncol Hematol. 2012 Nov;84(2):213-23
pubmed: 22503530